Alcon Current Ratio 2019-2022 | ALC

Current and historical current ratio for Alcon (ALC) from 2019 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Alcon current ratio for the three months ending June 30, 2022 was 2.16.
Alcon Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-06-30 $5.02B $2.32B 2.16
2022-03-31 $4.89B $2.25B 2.18
2021-12-31 $5.39B $2.47B 2.18
2021-09-30 $5.29B $2.38B 2.23
2021-06-30 $5.02B $2.20B 2.28
2021-03-31 $4.97B $1.97B 2.53
2020-12-31 $4.99B $2.26B 2.21
2020-09-30 $4.78B $2.09B 2.29
2020-06-30 $4.63B $2.08B 2.23
2020-03-31 $4.13B $2.13B 1.93
2019-12-31 $4.24B $2.30B 1.84
2019-09-30 $4.22B $2.25B 1.88
2019-06-30 $4.14B $3.82B 1.09
2019-03-31 $0.00B 0.00
2018-12-31 $0.00B 0.00
2018-09-30 $0.00B 0.00
2018-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $28.513B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Edwards Lifesciences (EW) United States $51.226B 36.24
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Globus Medical (GMED) United States $5.928B 30.24
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23